Literature DB >> 15948040

Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel.

Laïla Boulmedarat1, Géraldine Piel, Amélie Bochot, Sylviane Lesieur, Luc Delattre, Elias Fattal.   

Abstract

PURPOSE: The aim of the present study was to design a new mucosal drug delivery system composed of liposomes dispersed within a bioadhesive hydrogel containing methyl-beta-cyclodextrin (Me(beta)CD) for controlled drug release.
METHODS: A hydrophilic model molecule, inulin, was encapsulated within positively charged and PEG-ylated liposomes and its release was measured in the presence of Me(beta)CD after vesicle dispersion within the bioadhesive Carbopol 974P gel. Freeze-fracture electron microscopy (FFEM) was used to follow liposome morphological changes when dispersed within the hydrogel. Liposome-Me(beta)CD interactions were investigated by turbidity monitoring during continuous addition of Me(beta)CD to liposomes and by FFEM.
RESULTS: Inulin diffusion within the gel was influenced by Carbopol 974P concentration since no gel erosion occurred. When dispersed within the gel, positively charged liposomes displayed a higher stability than PEG-ylated vesicles. In the presence of Me(beta)CD, higher amounts of free inulin were released from liposomes, especially in Carbopol-free system. Me(beta)CD appeared to diffuse towards lipid vesicles and permeabilized their bilayer allowing inulin leakage. Indeed, freeze-fracture experiments and liposome turbidity monitoring have shown that Me(beta)CD behaved as a detergent behavior, resulting in lipid vesicle solubilization.
CONCLUSION: is able to mediate, within a bioadhesive hydrogel, the release of a liposome-encapsulated molecule allowing further application of this delivery system for mucosal administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948040     DOI: 10.1007/s11095-005-4591-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

1.  Liposomes containing drugs for treatment of vaginal infections.

Authors:  Z Pavelić; N Skalko-Basnet; I Jalsenjak
Journal:  Eur J Pharm Sci       Date:  1999-08       Impact factor: 4.384

Review 2.  Permeability issues in nasal drug delivery.

Authors:  Priyanka Arora; Shringi Sharma; Sanjay Garg
Journal:  Drug Discov Today       Date:  2002-09-15       Impact factor: 7.851

3.  Bioadhesive polymers in peptide drug delivery.

Authors:  D Harris; J R Robinson
Journal:  Biomaterials       Date:  1990-11       Impact factor: 12.479

Review 4.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

Review 5.  Developments in buccal drug delivery.

Authors:  M E de Vries; H E Boddé; J C Verhoef; H E Junginger
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1991       Impact factor: 4.889

6.  The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.

Authors:  H W Frijlink; A C Eissens; N R Hefting; K Poelstra; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

7.  Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving the use of detergents. 1. Solubilization of large unilamellar liposomes (prepared by reverse-phase evaporation) by triton X-100, octyl glucoside, and sodium cholate.

Authors:  M T Paternostre; M Roux; J L Rigaud
Journal:  Biochemistry       Date:  1988-04-19       Impact factor: 3.162

8.  Cellular cholesterol efflux mediated by cyclodextrins.

Authors:  E P Kilsdonk; P G Yancey; G W Stoudt; F W Bangerter; W J Johnson; M C Phillips; G H Rothblat
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

9.  Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Authors:  Z Shao; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

10.  Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides.

Authors:  A Bochot; E Fattal; A Gulik; G Couarraze; P Couvreur
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.